GL1X · GenesisL1 explorer

Research workbench

PCSK9(DELTACRD) in complex with cyclic peptide 30

Analyse PCSK9(DELTACRD) in complex with cyclic peptide 30 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6XIB
Type
protein
Length
389 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proprotein convertase SUBTILISIN/KEXIN type 9; Peptide 30
EC
3.4.21.-
UniProt
Q8NBP7
Ligands
B74
Pockets
1 · best druggability 0.34

Structure

x-ray diffraction · 3 distinct chains · 30% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProprotein convertase SUBTILISIN/KEXIN type 9 (EC 3.4.21.-)protein9230% helix, 39% strandQ8NBP7
BProprotein convertase SUBTILISIN/KEXIN type 9 (EC 3.4.21.-)protein28730% helix, 24% strandQ8NBP7
IPeptide 30protein100% helix, 20% strand—

Ligands and binding sites

  • B74 · (3-methylphenyl)methanol · ligand · chains B, I
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1580.340.7717empty

Interfaces

2 interfaces between chains.

  • A–B · 1384 Ų buried · 28 hydrogen bonds · protein-protein
  • B–I · 558 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 disulfide, 3 modified, 2 covalent (disulfide, nonstandard, covalent ligand).

Compared structures

  • 6XIB · PCSK9(deltaCRD) in complex with cyclic peptide 30 · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.